Home
Advertisement & Sponsorship Options
Download Our Media Kit
Changing Physician Behavior
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Resources
Membership
Agenda
Join Today
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Advertisement & Sponsorship Options
Download Our Media Kit
Changing Physician Behavior
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Resources
Membership
Agenda
Join Today
Video
Careers
Home
Tags
Venetoclax
Tag: venetoclax
ASH 2022: Positive OS Data for Patients in R/R AML in...
Danielle Garcia
-
November 3, 2022
Study Shows how a New Delivery Strategy may Improve Chemotherapy for...
Danielle Garcia
-
September 20, 2022
Breakthrough Therapy Designation for Venetoclax + Azacitidine in Myelodysplastic Syndromes
Editorial Team
-
July 20, 2021
Combination Therapy Achieved Durable Remission for Patients with CLL
Editorial Team
-
June 11, 2021
Combinability: Addressing Unmet Need in AML
David A. Roth, M.D.
-
August 20, 2020
VIALE-A Study Showed Venetoclax + Azacitidine Reduced Risk of Death in...
Peter Hofland
-
August 12, 2020
Study Shows Positive Topline Results from Phase III Trial of Venetoclax...
Editorial Team
-
March 23, 2020
Combination of Fimepinostat + Venetoclax Generally Well-tolerated
Peter Hofland
-
December 6, 2019
US FDA Lifts Partial Clinical Hold on Phase III Study of...
Peter Hofland
-
June 24, 2019
FDA Approves Venetoclax as a Chemotherapy-Free Combination in Previously Untreated CLL
Peter Hofland
-
May 15, 2019
1
2
Page 1 of 2
LATEST NEWS
Preoperative Intravenous Iron Reduces the Need for Blood Transfusion in Colorectal Cancer Surgery
Peter Hofland
-
November 25, 2023
Are The Catholic Church and Its Hospitals A Marriage Made in Heaven?
Editorial Team
-
November 24, 2023
Microbubbles: The Unlikely Key to Providing Accessible and Effective Cancer Treatments
Brandon H. McNaughton, Ph.D.
-
November 23, 2023
Activating Bitter Taste Receptors May Kill Certain Cancer Cells
Editorial Team
-
November 22, 2023
GRP78 – A Promising Target for CAR T-cells Helps Cancer Trick the Immune System
Editorial Team
-
November 21, 2023
X